ADMA Latest Headlines

ADMA Biologics Faces Federal Securities Lawsuit Over Alleged Channel Stuffing Scheme and Undisclosed Related Party Transactions 

at www.tipranks.com (Mon, 15-Jun 1:21 PM)

ADMA: Buy Rating Reiterated on Strong IG Product Momentum, Conservative Expectations and Unchanged $18 Price Target

at www.tipranks.com (Mon, 15-Jun 7:15 AM)

Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts

at www.tipranks.com (Sat, 13-Jun 5:01 AM)

ADMA Faces Securities Investigation After Channel Stuffing Allegations—Stock Under Scrutiny Amid Revenue Growth Questions

Market Chameleon (Thu, 14-May 11:23 AM)

ADMA Biologics Faces Legal Scrutiny After Allegations of Artificial Revenue Growth by Culper Research

Market Chameleon (Fri, 8-May 9:51 AM)

FDA Expands ADMA’s ASCENIV Label to Include Children as Young as Two—What This Means for Pediatric Immune Treatment

Market Chameleon (Mon, 4-May 7:30 AM)

ADMA Faces Securities Fraud Investigation After Short Report Alleges Channel Stuffing Scheme

Market Chameleon (Fri, 27-Mar 10:29 AM)

ADMA Biologics Defends ASCENIV: Demand Hits Record Highs and Inventory Remains in Line with Industry Standards

Market Chameleon (Fri, 27-Mar 7:50 AM)

ADMA Biologics Addresses Short-Seller Report—Company Reaffirms Commitment to Transparency

Market Chameleon (Wed, 25-Mar 8:20 AM)